CENTRAL SURGERY — All Prescriptions & Medications — Page 12
Practice Code: H84030 | SURBITON, KT6 6EZ
Showing results 551-600 of 641
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Tablets/capsules micronutrient supplement (0913282) | 15 | 720 | £510 | +43.2% ▲ |
| Tube feed 1.5 kcal/ml (0914011) | 15 | 400.0K | £6.6K | +53.2% ▲ |
| Pyridostigmine bromide | 15 | 3,000 | £248 | -12.4% ▼ |
| 15 | 170 | £227 | +37.0% ▲ | |
| 15 | 250 | £838 | +126.7% ▲ | |
| 15 | 1,150 | £353 | +155.1% ▲ | |
| 15 | 1,230 | £1.9K | -18.5% ▼ | |
| 15 | 710 | £986 | -14.9% ▼ | |
| 15 | 1,028 | £356 | -22.4% ▼ | |
| Naloxegol | 14 | 392 | £687 | +1.5% vs avg |
| Lormetazepam | 14 | 784 | £254 | +18.9% ▲ |
| Lofepramine hydrochloride | 14 | 10.4K | £9.7K | -53.2% ▼ |
| Rufinamide | 14 | 19.3K | £3.8K | -18.4% ▼ |
| Phenytoin | 14 | 21.0K | £171 | +27.5% ▲ |
| Quinine bisulfate | 14 | 784 | £151 | -63.9% ▼ |
| Alogliptin | 14 | 392 | £354 | -94.5% ▼ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 14 | 438 | £700 | +41.0% ▲ |
| Ready to serve infant formula, high energy (0913104) | 14 | 178.2K | £2.6K | +26.7% ▲ |
| Ready to serve preterm infant formula (0913111) | 14 | 15.8K | £174 | +59.5% ▲ |
| Powder 1.7 kcal/ml milkshake pre-thickened (0913671) | 14 | 476 | £1.0K | +66.5% ▲ |
| Tube feed 1.2 kcal/ml higher protein (0914011) | 14 | 322.0K | £5.0K | +84.7% ▲ |
| Methocarbamol | 14 | 1,176 | £75 | -70.8% ▼ |
| Aciclovir | 14 | 94 | £89 | +13.6% ▲ |
| Hepatitis B | 14 | 14 | £164 | +32.3% ▲ |
| 14 | 362 | £1.2K | -49.4% ▼ | |
| 14 | 54 | £392 | +135.8% ▲ | |
| 14 | 288 | £100 | -58.1% ▼ | |
| 14 | 1,000 | £3.4K | -2.2% ▼ | |
| 14 | 960 | £3.0K | +9.6% ▲ | |
| 14 | 340 | £1.7K | +48.3% ▲ | |
| Mebeverine hydrochloride compound preparations | 13 | 744 | £649 | +15.0% ▲ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 13 | 1,120 | £518 | -20.5% ▼ |
| Terazosin hydrochloride | 13 | 364 | £81 | -20.1% ▼ |
| Glycopyrronium bromide | 13 | 390 | £340 | -65.1% ▼ |
| Alimemazine tartrate | 13 | 1,300 | £1.4K | +0.5% vs avg |
| Exenatide | 13 | 52 | £954 | -25.9% ▼ |
| Fesoterodine fumarate | 13 | 364 | £30 | -67.0% ▼ |
| Other calcium supplement preparations | 13 | 780 | £349 | +73.4% ▲ |
| Febuxostat | 13 | 700 | £128 | -65.2% ▼ |
| Gentamicin sulfate | 13 | 140 | £266 | +136.6% ▲ |
| Prednisolone sodium phosphate | 13 | 290 | £171 | +1.9% vs avg |
| Carbomer 974P | 13 | 240 | £103 | +60.5% ▲ |
| 13 | 130 | £26 | +47.9% ▲ | |
| 13 | 13.0K | £837 | -65.9% ▼ | |
| 13 | 46 | £545 | -0.6% vs avg | |
| 13 | 390 | £577 | +107.3% ▲ | |
| Nadolol | 12 | 336 | £222 | +18.7% ▲ |
| Imipramine hydrochloride | 12 | 672 | £25 | -52.9% ▼ |
| Reboxetine | 12 | 1,596 | £479 | -22.1% ▼ |
| Tapentadol | 12 | 1,904 | £959 | -70.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.